President and Chief Executive Officer
Senior Vice President and Chief Financial Officer
Senior Vice President and General Counsel
Senior Vice President and Chief Business Officer
Rita Jain, M.D.
Senior Vice President, Chief Medical Officer
Prior to joining Akebia, Dr. Jain was the Vice President of Men’s and Women’s Health and Metabolic Development at AbbVie. From 2003-2016 she held positions of increasing responsibility, with over 10 years as either a Divisional Vice President or Vice President in Pharmaceutical Development at Abbott, and after the split at AbbVie. In addition to her work in Men’s and Women’s Health, and Metabolic Development, she also led activities in Pain, Respiratory and Cystic Fibrosis Development. Before AbbVie, she held management positions in the Arthritis, Inflammation and Pain Group at Searle (acquired by Pharmacia and subsequently Pfizer).
Prior to joining Searle, Dr. Jain was a faculty member at North Shore University Hospital in NY, with an academic appointment as Assistant Professor of Medicine, NYU School of Medicine.
Dr. Jain received her M.D. from the State University of New York at Stony Brook School of Medicine, and completed her training in Internal Medicine at Staten Island University Hospital followed by a Fellowship in Rheumatology at North Shore University Hospital and a Clinical Research Fellowship at the University of Texas Southwestern Medical Center, Dallas.
Mark De Rosch, PhD, FRAPS
Senior Vice President, Regulatory Affairs, Quality Assurance, and CMC
Senior Vice President of Human Resources
Senior Vice President of Corporate Communications and Investor Relations
Vice President, Corporate Operations
Karen Tubridy, PharmD
Senior Vice President, Chief Development Officer
Ms. Tubridy served as Senior Vice President, Clinical Development and Medical Affairs of Inspiration Biopharmaceuticals, Inc., a company that sold its hemophilia assets to Cangene Corporation and Baxter International in early 2013.
Prior to joining Inspiration Biopharmaceuticals, Ms. Tubridy served as Executive Director, Clinical Operations and Regulatory Affairs, Translational Medicine of Alexion Pharmaceuticals, when Taligen Therapeutics was acquired by Alexion Pharmaceuticals, and previously as Vice President of Clinical Operations and Regulatory Affairs of Taligen Therapeutics. Prior to that, Ms. Tubridy served as Vice President of Clinical Operations, Hemophilia at Biogen Idec, Inc. Ms. Tubridy received a B.S. and a Pharm.D. from the Massachusetts College of Pharmacy and Allied Health Sciences (MCPHS). Ms. Tubridy is a member of the Board of Trustees at MCPHS University.